Latest

The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆ The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected ◆ Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots ◆ A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals ◆ The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 ◆ Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs ◆ FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings ◆ Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions ◆ The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs ◆

Markets · 15 min delay

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

ISEQ9,241.3▲ +0.62%

NBI4,187.6▲ +1.14%

PFE28.42▼ -0.38%

AZN74.18▲ +0.81%

NVO103.55▲ +2.07%

ROG261.40▼ -0.55%

ABBV174.92▲ +0.29%

EUR/USD1.0842▼ -0.12%

Updated 06 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Galway

← All Irish trials

Every active and recruiting clinical study with an Irish site — searchable by condition, sponsor, phase and location. Refreshed daily from the ClinicalTrials.gov registry.

11

Recruiting now

18

Active studies

Recruiting

Effectiveness of Ultrasound-Guided Versus Traditional IV Insertion by Oncology Nurses in Adult Population Recieving Systemic Anti-cancer Therapy

Cancer
University of Galway · started 2025-10-20

📍 Galway

NCT07208175 on ClinicalTrials.gov ↗

Recruiting

Spyral InSight Study

Hypertension, Vascular Diseases, Cardiovascular Diseases
Medtronic Vascular · started 2025-06-09

📍 Galway

NCT07013929 on ClinicalTrials.gov ↗

Recruiting

Single vs. Multiple Fraction Trial of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastases/Progression

Oligometastatic Disease, Oligoprogression, Toxicity Due to Radiotherapy, Quality of Life
Robert Olson · started 2025-04-16

📍 Galway · Dublin · Cork · Waterford

NCT05784428 on ClinicalTrials.gov ↗

Recruiting

EXtubation Related Complications - the EXTUBE Study (EXTUBE)

Extubation
University Health Network, Toronto · started 2025-04-14

📍 Castlebar · Cork · Dublin · Galway · Waterford

NCT06442930 on ClinicalTrials.gov ↗

Recruiting Phase 3

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation

Critical Illness, Respiratory Failure
University of Turin, Italy · started 2024-08-01

📍 Galway

NCT05014581 on ClinicalTrials.gov ↗

Recruiting

Occupational Therapy-led Services for Adults Presenting Acutely With a Hand Condition

Hand Injuries
University of Limerick · started 2024-01-11

📍 Dublin · Galway · Limerick · Tipperary

NCT06399614 on ClinicalTrials.gov ↗

Active Phase 2

Neoadjuvant Trastuzumab Deruxtecan (T-DXd) With Response-directed Definitive Therapy in Early Stage HER2-positive Breast Cancer (SHAMROCK Study)

HER2-positive Breast Cancer
Cancer Trials Ireland · started 2023-10-26

📍 Galway · Dublin · Cork · Limerick

NCT05710666 on ClinicalTrials.gov ↗

Recruiting Phase 3

Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)

Community-acquired Pneumonia
Biotest · started 2023-09-09

📍 Dublin · Galway

NCT05722938 on ClinicalTrials.gov ↗

Recruiting

Understanding CARdiac Events in Breast Cancer

Breast Cancer, Cardiotoxicity, Cardiomyopathies, Chemotherapeutic Toxicity
National University of Ireland, Galway, Ireland · started 2023-01-14

📍 Galway · Mayo · Sligo

NCT05921279 on ClinicalTrials.gov ↗

Recruiting Phase 3

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Multiple Myeloma
European Myeloma Network B.V. · started 2022-09-08

📍 Cork · Dublin · Galway · Limerick

NCT05243797 on ClinicalTrials.gov ↗

Active

Evolut™ EXPAND TAVR II Pivotal Trial

Moderate Aortic Valve Stenosis
Medtronic Cardiovascular · started 2022-04-27

📍 Galway

NCT05149755 on ClinicalTrials.gov ↗

Recruiting Phase 3

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Hodgkin Lymphoma
University College, London · started 2022-04-14

📍 Dublin · Galway

NCT04685616 on ClinicalTrials.gov ↗

Recruiting Phase 1/Phase 2

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Advanced Solid Tumor, Non Small Cell Lung Cancer, Untreated Advanced NSCLC, 1st Line NSCLC
Synthekine · started 2022-01-25

📍 Dublin · Galway

NCT05098132 on ClinicalTrials.gov ↗

Active Phase 3

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Follicular Lymphoma, Marginal Zone Lymphoma
Incyte Corporation · started 2021-04-15

📍 Dublin · Galway

NCT04680052 on ClinicalTrials.gov ↗

Active Phase 3

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

Prostate Cancer
University of Sydney · started 2020-03-31

📍 Rathgar · Cork · Dublin · Galway

NCT04136353 on ClinicalTrials.gov ↗

Active Phase 3

Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals · started 2019-06-04

📍 Dublin · Cork · Galway

NCT03969004 on ClinicalTrials.gov ↗

Active Phase 3

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

Acute Myeloid Leukemia, Myelodysplastic Syndrome With Excess Blasts-2
Stichting Hemato-Oncologie voor Volwassenen Nederland · started 2019-03-01

📍 Cork · Dublin · Galway

NCT03839771 on ClinicalTrials.gov ↗

Active Phase 3

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer

Prostatic Neoplasms
University of Sydney · started 2014-03

📍 Beaumont · Dublin · Galway · Tallaght · Waterford

NCT02446405 on ClinicalTrials.gov ↗

No trials match your search.

Browse by location

Dublin · 68 Cork · 21 Galway · 18 Limerick · 9 Waterford · 6 Beaumont · 3 Sligo · 2 Letterkenny · 2 Mayo · 1 Mahon, Cork · 1 Castlebar · 1 Abbotstown · 1

Browse by condition

Breast Cancer · 4 Prostate Cancer · 4 Cancer · 3 Dementia · 3 Fallopian Tube Cancer · 3 Alzheimers Disease · 2 Alzheimers Disease, Familial · 2 Non Small Cell Lung Cancer · 2 Early Breast Cancer · 2 Primary Peritoneal · 2 Chronic Lymphocytic Leukemia · 2 Hypertension · 2 Vascular Diseases · 2 Cardiovascular Diseases · 2

Cite this page

Priya Life Science (2026). Clinical Trials in Ireland Tracker. Available at: https://priyalifescience.com/clinical-trials-ireland/city/galway (Accessed: 7 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — studies listing at least one Irish site, refreshed daily. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see our EU Clinical Trials Tracker.